BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
May 17, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Protectan CBLB502: Completed Phase I enrollment

Cleveland BioLabs completed enrollment of 100 healthy volunteers in a Phase I trial evaluating 4 dosing regimens, including a single injection of 25 or...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >